Upexi Insider Trades
NASDAQ: UPXIFinanceFinance: Consumer ServicesUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 6 · $1.07M
- Sales
- 0 · $0
- Shares bought / sold
- 450.00K / 0
- Net activity
- Net buying $1.1 million
Upexi insider activity
Over the last 12 months, Upexi insiders reported 11 transactions on SEC Form 4: 6 open-market purchases and 0 sales. Insiders bought $1.1 million and sold $0 worth of stock, for net insider buying of $1.1 million. The most recent filing shows Rudick Brian Benjamin (Chief Strategy Officer) reporting a transaction in 400,000 shares on Jul 3, 2026.
Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put UPXI's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
UPXI insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Jul 3, 2026 | MARSHALL ALLANChief Executive Officer | Award | 2,000,000 | — | Form 4 |
| Jul 3, 2026 | Dugan LawrenceDirector | Award | 100,000 | — | Form 4 |
| Jul 3, 2026 | Salkind GeneDirector | Award | 100,000 | — | Form 4 |
| Jul 3, 2026 | Norstrud Andrew JamesChief Financial Officer | Award | 400,000 | — | Form 4 |
| Jul 3, 2026 | Rudick Brian BenjaminChief Strategy Officer | Award | 400,000 | — | Form 4 |
| Dec 23, 2025 | MARSHALL ALLANChief Executive Officer | Buy | 50,000 | $90.00K | Form 4 |
| Dec 16, 2025 | MARSHALL ALLANChief Executive Officer | Buy | 50,000 | $103.50K | Form 4 |
| Dec 15, 2025 | MARSHALL ALLANChief Executive Officer | Buy | 100,000 | $207.00K | Form 4 |
| Nov 20, 2025 | Salkind GeneDirector | Buy | 50,000 | $127.50K | Form 4 |
| Nov 17, 2025 | Salkind GeneDirector | Buy | 100,000 | $281.00K | Form 4 |
| Nov 17, 2025 | Salkind GeneDirector | Buy | 100,000 | $265.00K | Form 4 |
| Oct 1, 2025 | Norstrud Andrew JamesChief Financial Officer | Award | 240,000 | — | Form 4 |
| Oct 1, 2025 | MARSHALL ALLANChief Executive Officer | Award | 1,600,000 | — | Form 4 |
| Jul 22, 2025 | Dugan LawrenceDirector | Buy | 4,000 | $30.00K | Form 4 |
| Jul 16, 2025 | MARSHALL ALLANChief Executive Officer | Award | 1,200,000 | — | Form 4 |
| Jul 16, 2025 | Williams Thomas CharlesDirector | Award | 50,000 | — | Form 4 |
| Jul 16, 2025 | Williams Thomas CharlesDirector | Award | 50,000 | — | Form 4 |
| Jul 16, 2025 | Dugan LawrenceDirector | Buy | 1,000 | $5.60K | Form 4 |
| Jul 16, 2025 | Dugan LawrenceDirector | Buy | 10,000 | $57.00K | Form 4 |
| Jul 16, 2025 | Dugan LawrenceDirector | Award | 50,000 | — | Form 4 |
| Jul 16, 2025 | Dugan LawrenceDirector | Award | 50,000 | — | Form 4 |
| Jul 16, 2025 | Norstrud Andrew JamesChief Financial Officer | Award | 250,000 | — | Form 4 |
| Jul 16, 2025 | Rudick Brian BenjaminCSO | Award | 400,000 | — | Form 4 |
| Jul 16, 2025 | Salkind GeneDirector | Award | 150,000 | — | Form 4 |
| Jul 16, 2025 | Salkind GeneDirector | Award | 50,000 | — | Form 4 |
| Jul 15, 2025 | Dugan LawrenceDirector | Buy | 1,000 | $5.17K | Form 4 |
| Jul 11, 2025 | MARSHALL ALLANChief Executive Officer | Buy | 161,943 | $800.00K | Form 4 |
| Jul 11, 2025 | Salkind GeneDirector | Buy | 20,243 | $100.00K | Form 4 |
| Apr 17, 2025 | Salkind GeneDirector | Buy | 241,229 | $550.00K | Form 4 |
| Apr 17, 2025 | MARSHALL ALLANChief Executive Officer | Award | 75,000 | — | Form 4 |
| Apr 17, 2025 | MARSHALL ALLANChief Executive Officer | Buy | 657,895 | $1.50M | Form 4 |
| Apr 17, 2025 | Norstrud Andrew JamesChief Financial Officer | Award | 100,000 | — | Form 4 |
| Apr 17, 2025 | Norstrud Andrew JamesChief Financial Officer | Buy | 43,860 | $100.00K | Form 4 |
| Mar 12, 2024 | MARSHALL ALLANCHIEF EXECUTIVE OFFICER | Buy | 64,150 | $36.57K | Form 4 |
| Mar 11, 2024 | MARSHALL ALLANCHIEF EXECUTIVE OFFICER | Buy | 13,623 | $8.17K | Form 4 |
| Mar 5, 2024 | MARSHALL ALLANCHIEF EXECUTIVE OFFICER | Buy | 103,013 | $72.11K | Form 4 |
| Dec 15, 2023 | MARSHALL ALLANCHIEF EXECUTIVE OFFICER | Buy | 4,535 | $4.13K | Form 4 |
| Dec 14, 2023 | MARSHALL ALLANCHIEF EXECUTIVE OFFICER | Buy | 8,381 | $8.21K | Form 4 |
| Dec 7, 2023 | MARSHALL ALLANCHIEF EXECUTIVE OFFICER | Buy | 90,001 | $84.95K | Form 4 |
| Dec 5, 2023 | MARSHALL ALLANCHIEF EXECUTIVE OFFICER | Buy | 19,296 | $16.29K | Form 4 |
| Dec 4, 2023 | MARSHALL ALLANCHIEF EXECUTIVE OFFICER | Buy | 34,178 | $24.36K | Form 4 |
| Jun 28, 2023 | MARSHALL ALLANChief Executive Officer | Buy | 24,000 | $54.17K | Form 4 |
| Jun 27, 2023 | MARSHALL ALLANChief Executive Officer | Buy | 24,000 | $57.29K | Form 4 |
| Jun 26, 2023 | MARSHALL ALLANChief Executive Officer | Buy | 23,952 | $58.25K | Form 4 |
| Jun 23, 2023 | MARSHALL ALLANChief Executive Officer | Buy | 7,893 | $18.85K | Form 4 |
| Jun 22, 2023 | MARSHALL ALLANChief Executive Officer | Buy | 100 | $227.50 | Form 4 |
| May 22, 2023 | MARSHALL ALLANCHIEF EXECUTIVE OFFICER | Buy | 22,776 | $77.74K | Form 4 |
| Mar 17, 2023 | MARSHALL ALLANCHIEF EXECUTIVE OFFICER | Buy | 4,095 | $18.07K | Form 4 |
| Mar 16, 2023 | MARSHALL ALLANCHIEF EXECUTIVE OFFICER | Buy | 4,572 | $20.48K | Form 4 |
| Mar 15, 2023 | MARSHALL ALLANCHIEF EXECUTIVE OFFICER | Buy | 4,334 | $18.75K | Form 4 |
| Dec 16, 2022 | MARSHALL ALLANCHIEF EXECUTIVE OFFICER | Buy | 4,578 | $16.44K | Form 4 |
| Dec 15, 2022 | MARSHALL ALLANCHIEF EXECUTIVE OFFICER | Buy | 2,725 | $9.97K | Form 4 |
| Dec 14, 2022 | MARSHALL ALLANCHIEF EXECUTIVE OFFICER | Buy | 10,000 | $37.50K | Form 4 |
| Dec 9, 2022 | MARSHALL ALLANCHIEF EXECUTIVE OFFICER | Buy | 12,000 | $49.32K | Form 4 |
| Dec 1, 2022 | MARSHALL ALLANCHIEF EXECUTIVE OFFICER | Buy | 18,475 | $73.16K | Form 4 |
| Mar 30, 2022 | Salkind GeneDirector | Buy | 125,000 | $500.00K | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4